Evidence map›Paper›PMID 42192088›Full record

ArticleCardiovascular intervention and therapeutics2026

Cardiac damage stages at follow-up and subsequent clinical outcomes in patients with severe aortic stenosis.

Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, Shinichi Shirai, Takeshi Kitai, Hiroyuki Tabata, Nobuhisa Ohno, Ryosuke Murai, Kohei Osakada, Koichiro Murata and 33 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular intervention and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Yasuaki TakejiDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Tomohiko TaniguchiDepartment of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
Takeshi MorimotoDepartment of Clinical Epidemiology, Hyogo Medical University, Nishinomiya, Japan.
Shinichi ShiraiDivision of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
Takeshi KitaiDepartment of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
Hiroyuki TabataDivision of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
Nobuhisa OhnoDivision of Cardiovascular Surgery, Kokura Memorial Hospital, Kitakyushu, Japan.
Ryosuke MuraiDepartment of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
Kohei OsakadaDepartment of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.
Koichiro MurataDepartment of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Masanao NakaiDepartment of Cardiovascular Surgery, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Hiroshi TsuneyoshiDepartment of Cardiovascular Surgery, Shizuoka General Hospital, Shizuoka, Japan.
Tomohisa TadaDepartment of Cardiology, Shizuoka General Hospital, Shizuoka, Japan.
Masashi AmanoDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Japan.
Shin WatanabeDepartment of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hiroki ShiomiDepartment of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hirotoshi WatanabeDepartment of Cardiology, Hirakata Kohsai Hospital, 1-2-1 Fujisaka Higashi-machi, Hirakata, 573, 0153, Japan.
Yusuke YoshikawaDepartment of Biostatistics, National Cerebral and Cardiovascular Center, Suita, Japan.
Ryusuke NishikawaDepartment of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuki ObayashiDepartment of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ko YamamotoDivision of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
Mamoru ToyofukuDepartment of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Shojiro TatsushimaDepartment of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Norio KanamoriDivision of Cardiology, Shimada General Medical Center, Shimada, Japan.
Makoto MiyakeDepartment of Cardiology, Tenri Hospital, Tenri, Japan.
Hiroyuki NakayamaDepartment of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
Kazuya NagaoDepartment of Cardiovascular Center, Osaka Red Cross Hospital, Osaka, Japan.
Masayasu IzuharaDepartment of Cardiology, Kishiwada City Hospital, Kishiwada, Japan.
Kenji NakatsumaDepartment of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.
Moriaki InokoCardiovascular Center, The Tazuke Kofukai Medical Research Institute Kitano hospital, Osaka, Japan.
Takanari FujitaDepartment of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Masahiro KimuraDepartment of Cardiology, Koto Memorial Hospital, Higashiomi, Japan.
Mitsuru IshiiDepartment of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Shunsuke UsamiDepartment of Cardiology, Kansai Electric Power Hospital, Osaka, Japan.
Fumiko NakazekiDepartment of Cardiology, Japanese Red Cross Otsu Hospital, Otsu, Japan.
Kiyonori TogiDivision of Cardiology, Kindai University Nara hospital, Ikoma, Japan.
Yasutaka InuzukaDepartment of Cardiology, Shiga General Hospital, Moriyama, Japan.
Kenji AndoDivision of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
Tatsuhiko KomiyaDepartment of Cardiovascular Surgery, Kurashiki Central Hospital, Kurashiki, Japan.
Koh OnoDepartment of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kenji MinatoyaDepartment of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takeshi KimuraDepartment of Cardiology, Hirakata Kohsai Hospital, 1-2-1 Fujisaka Higashi-machi, Hirakata, 573, 0153, Japan. taketaka@kuhp.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-5665-4076
CURRENT AS registry-2 Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data on the impact of cardiac damage based on follow-up echocardiography at 1 year in patients with severe aortic stenosis (AS) are insufficient. The current study included 1991 patients with severe AS who underwent follow-up echocardiography at 1 year after the initial AVR strategy (n = 1211) and conservative management (n = 780) in the CURRENT AS Registry-2. In the initial AVR group, the higher adjusted risk for stage 1, 2, and 3 or 4 relative to stage 0 was not significant for the primary outcome (a composite of all-cause death or hospitalization for heart failure) (hazard ratio [HR] = 0.51, 95% confidence interval [CI] = 0.25-1.04; HR = 0.71, 95% CI = 0.39-1.29; and HR = 0.57, 95% CI = 0.22-1.48). Meanwhile, in the conservative management group, it was significant for the primary outcome (HR = 2.33, 95% CI = 0.99-5.52; HR = 2.89, 95% CI = 1.30-6.40; and HR = 6.44, 95% CI = 2.62-15). A significant association was observed between the initial treatment strategies and effects of cardiac damage stages at 1 year on the primary outcome (P interaction = 0.003). Cardiac damage stages based on follow-up echocardiography at 1 year were useful for prognostic stratification in patients who received conservative management, but not in those who underwent initial AVR. UMINID: UMIN000034169.

Indexed as

Aortic Valve StenosisHeart FailureAgedAged, 80 and overConservative TreatmentEchocardiographyFemaleFollow-Up StudiesHumansMaleRegistriesSeverity of Illness IndexAortic valve stenosisHeart failureTranscatheter aortic valve replacement

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.